Elsevier

Brain Research

Volume 666, Issue 2, 15 December 1994, Pages 151-167
Brain Research

Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice

https://doi.org/10.1016/0006-8993(94)90767-6Get rights and content

Abstract

The amyloid precursor protein (APP) is involved in Alzheimer's disease (AD) because its degradation products accumulate abnormally in AD brains and APP mutations are associated with early onset AD. However, its role in health and disease appears to be complex, with different APP derivatives showing either neurotoxic or neurotrophic effects in vitro. To elucidate the effects APP has on the brain in vivo, cDNAs encoding different forms of human APP (hAPP) were placed downstream of the neuron-specific enolase (NSE) promoter. In multiple lines of NSE-hAPP transgenic mice neuronal overexpression of hAPP was accompanied by an increase in the number of synaptophysin immunoreactive (SYN-IR) presynaptic terminals and in the expression of the growth-associated marker GAP-43. In lines expressing moderate levels of hAPP751 or hAPP695, this effect was more prominent in homozygous than in heterozygous transgenic mice. In contrast, a line with several-fold higher levels of hAPP695 expression showed less increase in SYN-IR presynaptic terminals per amount of hAPP expressed than the lower expressor lines and a decrease in synaptotrophic effects in homozygous compared with heterozygous offspring. Transgenic mice (2–24 months of age) showed no evidence for amyloid deposits or neurodegeneration. These findings suggest that APP may be important for the formation/maintenance of synapses in vivo and that its synaptotrophic effects may be critically dependent on the expression levels of different APP isoforms. Alterations in APP expression, processing or function could contribute to the synaptic pathology seen in AD.

References (95)

  • MasliahE. et al.

    Amyloid precursor protein is localized in growing neurites of neonatal rat brain

    Brain Res.

    (1992)
  • MasliahE. et al.

    Patterns of aberrant sprouting in Alzheimer's disease

    Neuron

    (1991)
  • MatthewsD.A. et al.

    An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. II. Reappearance of morphologically normal synaptic contacts

    Brain Res.

    (1976)
  • MattsonM.P. et al.

    β-Amyloid precursor protein metabolites and loss of neuronal Ca2 + homeostasis in Alzheimer's disease

    Trends Neurosci.

    (1993)
  • MattsonM.P. et al.

    Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein

    Neuron

    (1993)
  • MullanM. et al.

    Genetic and molecular advances in Alzheimer's disease

    Trends Neurosci.

    (1993)
  • NeveR.L. et al.

    Expression of the Alzheimer amyloid precursor gene transcripts in the human brain

    Neuron

    (1988)
  • OltersdorfT. et al.

    The Alzheimer amyloid precursor protein: identification of a stable intermediate in the biosynthetic/degradative pathway

    J. Biol. Chem.

    (1990)
  • ReglandB. et al.

    The role of amyloid β-protein in Alzheimer's disease

    Lancet

    (1992)
  • SakimuraK. et al.

    The structure and expression of neuron-specific enolase gene

    Gene

    (1987)
  • SchubertW. et al.

    Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites

    Brain Res.

    (1991)
  • SelkoeD.J.

    Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease

    Trends Neurosci.

    (1993)
  • SimanR. et al.

    Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage

    Neuron

    (1989)
  • SinhaS. et al.

    The protease inhibitory properties of the Alzheimer's β-amyloid precursor protein

    J. Biol. Chem.

    (1990)
  • VidalF. et al.

    A murine sequence-specific DNA binding protein shows extensive local similarities to the amyloid precursor protein

    Biochem. Biophys. Res. Commun.

    (1992)
  • YamadaT. et al.

    Neuron-specific splicing of the Alzheimer amyloid precursor protein gene in a mini-gene system

    Biochem. Biophys. Res. Commun.

    (1993)
  • YamaguchiH.

    Immunoelectron microscopic localization of amyloid β protein in the diffuse plaques of Alzheimer-type dementia

    Brain Res.

    (1990)
  • AlfordM.F. et al.

    A simple dot-immunobinding assay for the quantification of synaptophysin-like immunoreactivity in human brain

    J. Histochem. Cytochem.

    (1994)
  • AndersonK.J. et al.

    Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats

    J. Comp. Neurol.

    (1986)
  • AraiH. et al.

    Expression patterns of β-amyloid precursor protein (β-APP) in neural and nonneural tissues from Alzheimer's disease and control subjects

    Ann. Neurol.

    (1991)
  • BadleyJ.E. et al.

    A simple, rapid method for the purification of poly(A)+ RNA

    BioTechniques

    (1988)
  • BrownM.C. et al.

    Chapter 9: Excess connections and their elimination

  • ClarkR.F. et al.

    Molecular genetics of Alzheimer's disease

    Arch. Neurol.

    (1993)
  • CordellB.

    β-Amyloid formation as a potential therapeutic target for Alzheimer's disease

    Annu. Rev. Pharmacol. Toxicol.

    (1994)
  • CotmanC.W. et al.

    Cell biology of synaptic plasticity

    Science

    (1984)
  • EverallI. et al.

    A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia

    J. Neuropathol. Exp. Neurol.

    (1993)
  • GandyS.E. et al.

    Alzheimer β/A4-amyloid precursor protein: evidence for putative amyloidogenic fragment

    J. Neurochem.

    (1992)
  • GoateA. et al.

    Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

    Nature

    (1991)
  • HardyJ.A. et al.

    Alzheimer's disease: the amyloid cascade hypothesis

    Science

    (1992)
  • HigginsL.S. et al.

    Transgenic mice expressing human β-APP751, but not mice expressing β-APP695, display early Alzheimer's disease-like histopathology

    Ann. NY Acad. Sci.

    (1993)
  • HoganB. et al.
  • JoachimC.L. et al.

    Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

    Nature

    (1989)
  • JuckerM. et al.

    Age-associated inclusions in normal and transgenic mouse brain

    Science

    (1992)
  • KangJ. et al.

    The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

    Nature

    (1987)
  • KatzmanR. et al.

    Advances in Alzheimer's disease

    FASEB. J.

    (1991)
  • KitaguchiN. et al.

    Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

    Nature

    (1988)
  • KooE.H. et al.

    Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth

  • Cited by (259)

    • Functions of amyloid precursor protein in metabolic diseases

      2021, Metabolism: Clinical and Experimental
      Citation Excerpt :

      Peptides produced by non-amyloidogenic processing of APP have protective effects on metabolic regulation. For example, sAPPα has been implicated in various cellular processes, including promoting synaptogenesis [40], and they serve a memory-enhancing function by stimulating the proliferation of neural progenitors [41] and promoting neurite extension [42]. Furthermore, the expression of sAPPα in APP-deficient mice is sufficient to recover the anatomical, behavioral, and electrophysiological abnormalities [43], clearly showing the protective function of sAPPα.

    • AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease

      2018, Alzheimer's and Dementia
      Citation Excerpt :

      Further studies have demonstrated in vivo that second generation M1 selective agonists were capable of reducing the production of toxic Aβ species by shifting the APP processing toward a nonamyloidogenic pathway [16]. As such, these agents should facilitate the release of soluble APPα [19], a fragment known to display synaptogenic properties, even in the adult and fully differentiated CNS [54,55]. In 3×Tg-AD mice, AF710B decreased Aβ levels as well as BACE-1 and C99 fragments [21].

    View all citing articles on Scopus
    **

    Present address: Research Unit for Experimental Neuropathology, Austrian Academy for Sciences, A-1090 Vienna, Austria.

    View full text